HRSA approves 10 drugmakers for revised 340B rebate pilot program covering 21 drugs
The Trump administration released a list of 10 pharmaceutical companies, including AbbVie, Merck, and Pfizer, that will be allowed to shift from upfront discounts to after-the-fact rebates on 21 drugs in the 340B drug discount program starting January 1. The revised pilot program includes more manufacturers than the administration's first attempt at a rebate program.
